From Chicago to Chapel Hill, Boston to Basel, Sandhill to Singapore...

We believe that shareholder value is maximized by serving the needs of emerging growth companies throughout the entire development and investment horizon. Because financing is fundamental to the success of all growth companies, Healthios has developed a global capital markets capability dedicated exclusively to the emerging growth community -- from the $10 million private placement to the $50 million IPO, and the $50 "pre-money" to the $300 million "target market cap".

Upon this unique capital markets foundation, we are uniquely capable of executing M&A and partnering transactions which maximize the strategic potential of our clients.